Chronic Hypoparathyroidism
Conditions
Keywords
Registry study, Chronic hypoparathyroidism
Brief summary
This multicenter registry study aims to understand the status of diagnosis and treatment, quality of life, medical costs and unmet medical needs of adult patients with chronic hypoparathyroidism in China.
Detailed description
Hypoparathyroidism (HP) is a rare (orphan) endocrine disease with low calcium and inappropriately low circulating parathyroid hormone levels, most often in adults secondary to thyroid surgery. The present study contains four parts. The first part is a multicenter registry study. According to our predefined search criteria determined through pilot study, all patients admitted between June 1, 2020 and May 31, 2021 will be searched from the hospital information system and patients diagnosed with HP and those with suspected HP will be retrieved. The diagnosis of all or a random sample of these patients will be reviewed by endocrinologists through medical records. Patients with a confirmed diagnosis of chronic HP will served as the study population of the first part of the study. The second part is a multicenter hospital-based survey, to investigate the missed diagnosis, quality of life, medical costs, medical experience and unmet medical needs in adult patients with chronic HP. All local patients with definite chronic HP and those with suspected HP will be invited to participate in the hospital on-site investigation. Among them, suspected HP patients need to first undergo necessary examinations to confirm the diagnosis of HP. The third part is the verification of the reliability and validity of two quality of life scales, the Short-Form Six-Dimension version 2 (SF-6Dv2) scale and Hypoparathyroidism Patient Experience Scale (HPES). The first 100 patients with chronic HP who participate in the on-site investigation in the Peking Union Medical College Hospital will be invited. The fourth part is a survey on physicians about the unmet need of chronic HP. All endocrinologists from each site will be invited to take part in the survey.
Interventions
No intervention would be taken
Sponsors
Peking Union Medical College Hospital
Shanghai 6th People's Hospital
First Hospital of China Medical University
Central South University
First Affiliated Hospital, Sun Yat-Sen University
West China Hospital
First Affiliated Hospital of Xinjiang Medical University
Peking University
Study design
Observational model
OTHER
Time perspective
OTHER
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
This study consists of four parts, the eligibility criteria of each part is described below: Part 1: Search criteria of chronic HP: Inclusion Criteria: * Existing diagnosis of HP
Exclusion criteria
* Age\<18 at the time of screening Search criteria of suspected HP: Inclusion Criteria: * Hypocalcemia plus neck surgery * Hypocalcemia plus convulsions/tetany/epilepsy * Hypocalcemia plus PTH\<upper limit, and no hypoalbuminemia * Hypocalcemia without any of the following conditions: neck surgery, convulsions/tetany/epilepsy, PTH testing, hypoalbuminemia, critical illness and vitamin D deficiency-related diseases.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The proportion of patients with different classification of hypoparathyroidism (HP) | 0 day （cross-sectional） | HP is classified into postsurgical and non-postsurgical HP. |
| The proportion of patients with different symptoms of HP | 0 day （cross-sectional） | The most common symptoms of HP include tetany, seizures, laryngospasm, numbness, blood in the urine, renal colic and vision loss. |
| The proportion of patients with positive Chvostek sign | 0 day （cross-sectional） | Including the situation at the time of diagnosis and the current situation |
| The proportion of patients with positive Trousseau's sign | 0 day （cross-sectional） | Including the situation at the time of diagnosis and the current situation |
| The proportion of patients with abnormal corrected calcium | 0 day （cross-sectional） | Including the situation at the time of diagnosis and the current situation |
| The proportion of patients with abnormal parathyroid hormone (PTH) | 0 day （cross-sectional） | The situation at the time of diagnosis |
| The proportion of patients with abnormal 24-hour urine calcium | 0 day （cross-sectional） | Including the situation at the time of diagnosis and the current situation |
| The proportion of patients with different first-visit reasons | 0 day （cross-sectional） | First-visit reason was excerpted from previous medical records |
| The proportion of patients with different first-visit departments | 0 day （cross-sectional） | First-visit department was excerpted from previous medical records |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| The prevalence of chronic HP in adults visiting top hospitals in China | 0 day （cross-sectional） | Number of patients diagnosed with chronic HP / Total number of outpatients and inpatients during the year |
| The proportion of patients with different unmet medical needs | 0 day （cross-sectional） | Unmet medical needs for HP treatment and quality of life by patients and physicians |
| The proportion of patients with chronic HP receiving treatment | 0 day （cross-sectional） | Number of patients receiving any kind of HP treatment/ Total number of patients diagnosed with chronic HP |
| The proportion of patients with chronic HP meeting treatment targets | 0 day （cross-sectional） | HP treatment targets defined as normal blood calcium levels or/+ normal urine calcium level |
| The proportion of patients with HP complications | 0 day （cross-sectional） | Number of patients with complications / Total number of patients with chronic HP |
| The proportion of patients with missed diagnosis of chronic HP | 0 day （cross-sectional） | Patients with missed diagnosis of chronic HP / Total number of patients with chronic HP |
| The proportion of patients with previous experience of misdiagnosis of HP | 0 day （cross-sectional） | Misdiagnosis experience of HP is defined as patients with chronic HP were previously diagnosed with other diseases due to related symptoms or hypocalcemia. |
| Median medical costs | 0 day （cross-sectional） | Medical costs contains of direct medical costs and indirect medical costs |
| The mean score of Short-Form Six-Dimension version 2 (SF-6Dv2) | 0 day （cross-sectional） | The SF-6Dv2 score ranges from 0.29 to 1, with higher scores indicating better performance. |
| The mean score of Hypoparathyroidism Patient Experience Scale (HPES) | 0 day （cross-sectional） | The HPES score ranges from 0 to 100, with lower scores indicating better performance. |
Countries
China
Outcome results
None listed